These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1237 related items for PubMed ID: 14671189

  • 1. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T, Honour JW, Conway GS.
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [Abstract] [Full Text] [Related]

  • 2. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
    Westerbacka J, Yki-Järvinen H, Vehkavaara S, Häkkinen AM, Andrew R, Wake DJ, Seckl JR, Walker BR.
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
    [Abstract] [Full Text] [Related]

  • 3. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
    Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH.
    J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
    [Abstract] [Full Text] [Related]

  • 4. Expression of 11beta-hydroxysteroid dehydrogenase 1 and 2 in subcutaneous adipose tissue of lean and obese women with and without polycystic ovary syndrome.
    Svendsen PF, Madsbad S, Nilas L, Paulsen SK, Pedersen SB.
    Int J Obes (Lond); 2009 Nov; 33(11):1249-56. PubMed ID: 19704410
    [Abstract] [Full Text] [Related]

  • 5. Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome.
    Vassiliadi DA, Barber TM, Hughes BA, McCarthy MI, Wass JA, Franks S, Nightingale P, Tomlinson JW, Arlt W, Stewart PM.
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3558-66. PubMed ID: 19567518
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cortisol metabolism after weight loss: associations with 11 β-HSD type 1 and markers of obesity in women.
    Rask E, Simonyte K, Lönn L, Axelson M.
    Clin Endocrinol (Oxf); 2013 May; 78(5):700-5. PubMed ID: 22233384
    [Abstract] [Full Text] [Related]

  • 9. Genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 predicts adrenal hyperandrogenism among lean women with polycystic ovary syndrome.
    Gambineri A, Vicennati V, Genghini S, Tomassoni F, Pagotto U, Pasquali R, Walker BR.
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2295-302. PubMed ID: 16551740
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients.
    Baudrand R, Domínguez JM, Carvajal CA, Riquelme A, Campino C, Macchiavello S, Bozinovic M, Morales M, Pizarro M, Solis N, Escalona A, Boza C, Arrese M, Fardella CE.
    Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348
    [Abstract] [Full Text] [Related]

  • 11. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
    Wiegand S, Richardt A, Remer T, Wudy SA, Tomlinson JW, Hughes B, Grüters A, Stewart PM, Strasburger CJ, Quinkler M.
    Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.
    Müssig K, Remer T, Haupt A, Gallwitz B, Fritsche A, Häring HU, Maser-Gluth C.
    Obesity (Silver Spring); 2008 Jun; 16(6):1256-60. PubMed ID: 18421276
    [Abstract] [Full Text] [Related]

  • 14. Urinary steroid excretion rates in acromegaly.
    Vierhapper H, Nowotny P, Waldhäusl W.
    Horm Res; 2005 Jun; 63(5):234-7. PubMed ID: 15900108
    [Abstract] [Full Text] [Related]

  • 15. A randomized placebo-controlled study on the effects of pioglitazone on cortisol metabolism in polycystic ovary syndrome.
    Glintborg D, Hermann AP, Hagen C, Jensen LT, Frystyk J, Bennett P, Flyvbjerg A, Andersen M.
    Fertil Steril; 2009 Mar; 91(3):842-50. PubMed ID: 18402944
    [Abstract] [Full Text] [Related]

  • 16. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
    Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
    [Abstract] [Full Text] [Related]

  • 17. Increased clearance of cortisol by 5beta-reductase in a subgroup of women with adrenal hyperandrogenism in polycystic ovary syndrome.
    Gambineri A, Forlani G, Munarini A, Tomassoni F, Cognigni GE, Ciampaglia W, Pagotto U, Walker BR, Pasquali R.
    J Endocrinol Invest; 2009 Mar; 32(3):210-8. PubMed ID: 19542736
    [Abstract] [Full Text] [Related]

  • 18. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
    Finken MJ, Andrews RC, Andrew R, Walker BR.
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
    [Abstract] [Full Text] [Related]

  • 19. Tissue-specific dysregulation of cortisol metabolism in human obesity.
    Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR.
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1418-21. PubMed ID: 11238541
    [Abstract] [Full Text] [Related]

  • 20. Steroid metabolism and excretion in severe anorexia nervosa: effects of refeeding.
    Wassif WS, McLoughlin DM, Vincent RP, Conroy S, Russell GF, Taylor NF.
    Am J Clin Nutr; 2011 May; 93(5):911-7. PubMed ID: 21367953
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.